Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study Meeting Abstract
| Authors: | Gonzalez-Martin, A.; Pothuri, B.; Vergote, I.; Christensen, R. D.; Graybill, W.; Mirza, M. R.; McCormick, C.; Lorusso, D.; Hoskins, P.; Freyer, G.; Baumann, K.; Jardon, K.; Redondo, A.; Moore, R. G.; Vulsteke, C.; O'Cearbhaill, R. E.; Lund, B.; Backes, F.; Barretina-Ginesta, P.; Haggerty, A. F.; Rubio-Perez, M. J.; Shahin, M. S.; Mangili, G.; Bradley, W. H.; Bruchim, I.; Sun, K.; Malinowska, I.; Li, Y.; Gupta, D.; Monk, B. J. |
| Abstract Title: | Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study |
| Meeting Title: | 21st International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 29 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Nov 2-5 |
| Meeting Location: | Athens, Greece |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2019-11-01 |
| Start Page: | A9 |
| End Page: | A10 |
| Language: | English |
| ACCESSION: | WOS:000523502500010 |
| DOI: | 10.1136/ijgc-2019-ESGO.9 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
